Koronis Pharmaceuticals

Biotechnology, Health Care, Therapeutics
Founded in 1998-01-01
Seattle, Washington, United States
http://www.koronispharma.com
For Profit

About Koronis Pharmaceuticals

Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism. It is a privately held biotechnology company developing antiviral therapeutics based on a novel mechanism, Viral Decay Accelerationâ„¢ (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV. It was founded in 1998 and is based in Seattle, Washington.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 5 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 21055000 USD
  • Last Funding: 55000 USD (Debt Financing)
  • Funding Status:

Technology Stack

Koronis Pharmaceuticals actively uses 5 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Therapeutics

Headquarters: Seattle, Washington, United States